

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 9.94930222 |
| 2 | complement activation (GO:0006956) | 7.59710124 |
| 3 | positive regulation of respiratory burst (GO:0060267) | 6.16719093 |
| 4 | protein activation cascade (GO:0072376) | 5.40325196 |
| 5 | negative regulation of mast cell activation (GO:0033004) | 5.13575137 |
| 6 | NADH metabolic process (GO:0006734) | 4.99964827 |
| 7 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.86097749 |
| 8 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.86097749 |
| 9 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.86097749 |
| 10 | signal peptide processing (GO:0006465) | 4.83346269 |
| 11 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.80288401 |
| 12 | humoral immune response (GO:0006959) | 4.66072224 |
| 13 | midgut development (GO:0007494) | 4.63795197 |
| 14 | T cell migration (GO:0072678) | 4.38067640 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34484948 |
| 16 | cytidine deamination (GO:0009972) | 4.16042565 |
| 17 | cytidine metabolic process (GO:0046087) | 4.16042565 |
| 18 | cytidine catabolic process (GO:0006216) | 4.16042565 |
| 19 | myeloid dendritic cell differentiation (GO:0043011) | 4.13602069 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.12346423 |
| 21 | glomerular filtration (GO:0003094) | 4.10385532 |
| 22 | regulation of respiratory burst (GO:0060263) | 4.08493046 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85741698 |
| 24 | myeloid dendritic cell activation (GO:0001773) | 3.85028871 |
| 25 | DNA deamination (GO:0045006) | 3.84163865 |
| 26 | nucleoside diphosphate catabolic process (GO:0009134) | 3.83874323 |
| 27 | respiratory tube development (GO:0030323) | 3.83071296 |
| 28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.81103718 |
| 29 | antibacterial humoral response (GO:0019731) | 3.79103586 |
| 30 | negative regulation of viral release from host cell (GO:1902187) | 3.74131700 |
| 31 | antimicrobial humoral response (GO:0019730) | 3.66572155 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.66037878 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.65674020 |
| 34 | tricarboxylic acid cycle (GO:0006099) | 3.64219748 |
| 35 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.62190391 |
| 36 | lung lobe morphogenesis (GO:0060463) | 3.60696703 |
| 37 | renal filtration (GO:0097205) | 3.59617307 |
| 38 | lung vasculature development (GO:0060426) | 3.56663374 |
| 39 | defense response to protozoan (GO:0042832) | 3.56131291 |
| 40 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.35734070 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28940594 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.26330871 |
| 43 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.25748657 |
| 44 | oxaloacetate metabolic process (GO:0006107) | 3.21504005 |
| 45 | lymphocyte migration (GO:0072676) | 3.21375966 |
| 46 | positive regulation of pseudopodium assembly (GO:0031274) | 3.19906754 |
| 47 | regulation of viral release from host cell (GO:1902186) | 3.18267153 |
| 48 | dendritic cell chemotaxis (GO:0002407) | 3.17944562 |
| 49 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.17852622 |
| 50 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.15139407 |
| 51 | apoptotic cell clearance (GO:0043277) | 3.14352994 |
| 52 | retina homeostasis (GO:0001895) | 3.12918770 |
| 53 | dendritic cell differentiation (GO:0097028) | 3.10560177 |
| 54 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.05534937 |
| 55 | ER overload response (GO:0006983) | 3.04676034 |
| 56 | hepatocyte apoptotic process (GO:0097284) | 3.01957389 |
| 57 | endocardial cushion development (GO:0003197) | 3.00746921 |
| 58 | negative regulation of bone resorption (GO:0045779) | 2.98112742 |
| 59 | COPI coating of Golgi vesicle (GO:0048205) | 2.95037632 |
| 60 | Golgi transport vesicle coating (GO:0048200) | 2.95037632 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.93474713 |
| 62 | establishment of apical/basal cell polarity (GO:0035089) | 2.92118729 |
| 63 | regulation of cellular extravasation (GO:0002691) | 2.90125569 |
| 64 | polarized epithelial cell differentiation (GO:0030859) | 2.89744168 |
| 65 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.89239319 |
| 66 | B cell mediated immunity (GO:0019724) | 2.86749633 |
| 67 | response to protozoan (GO:0001562) | 2.86225722 |
| 68 | type I interferon signaling pathway (GO:0060337) | 2.83940701 |
| 69 | cellular response to type I interferon (GO:0071357) | 2.83940701 |
| 70 | regulation of pseudopodium assembly (GO:0031272) | 2.82186525 |
| 71 | response to type I interferon (GO:0034340) | 2.80361427 |
| 72 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.80319317 |
| 73 | dendritic cell migration (GO:0036336) | 2.79187563 |
| 74 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.77428494 |
| 75 | mannose metabolic process (GO:0006013) | 2.76697738 |
| 76 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.71615086 |
| 77 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.71615086 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71593217 |
| 79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.71085085 |
| 80 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.71085085 |
| 81 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.71085085 |
| 82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.69996425 |
| 83 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.69148299 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.68055334 |
| 85 | negative regulation of B cell proliferation (GO:0030889) | 2.66431748 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.66077857 |
| 87 | T cell lineage commitment (GO:0002360) | 2.65674401 |
| 88 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.65092846 |
| 89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.65092846 |
| 90 | B cell receptor signaling pathway (GO:0050853) | 2.63564759 |
| 91 | ribosomal small subunit assembly (GO:0000028) | 2.63337113 |
| 92 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.63098245 |
| 93 | mitochondrion distribution (GO:0048311) | 2.61716246 |
| 94 | G1 DNA damage checkpoint (GO:0044783) | 2.61234113 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.60376680 |
| 96 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.59852348 |
| 97 | negative T cell selection (GO:0043383) | 2.59551622 |
| 98 | peptidyl-asparagine modification (GO:0018196) | 2.58900237 |
| 99 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.57241385 |
| 100 | lung morphogenesis (GO:0060425) | 2.53441924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55480883 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.06068238 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.68468301 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.65779050 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.08360586 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.04269662 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89779635 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.76520161 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.71851569 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64623222 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.58664376 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.58566055 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37010593 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31265560 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30001233 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21299577 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15246952 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13058868 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.11038589 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07627720 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99509770 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.88960915 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.85989688 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83315609 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.83143092 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.82975882 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.82615525 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82037658 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81706249 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81292656 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79328129 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.74995683 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71282995 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.65196464 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54823479 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53619521 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50773543 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49074812 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48482968 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46081440 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44320928 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44295462 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42249749 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41871315 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40248594 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40133427 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38614113 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.36079627 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35619652 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34799186 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32629068 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.30205886 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28452791 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25829070 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25003909 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23032396 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22238226 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22231106 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21579745 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21140162 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20358101 |
| 62 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.19141656 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17348923 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16811347 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15118543 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14660448 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14091329 |
| 68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14082915 |
| 69 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13522137 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13507947 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11617000 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11584447 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10506344 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07853059 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06609581 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.04923187 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02095235 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01333988 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00152236 |
| 80 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.99724811 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99187969 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98024046 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96521221 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96357532 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95545641 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94901334 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94409973 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94252736 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94066174 |
| 90 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93296473 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92381955 |
| 92 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92312339 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88903628 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88882245 |
| 95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88352186 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87316262 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87218516 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87208172 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.86377326 |
| 100 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86081685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.85040170 |
| 2 | MP0002166_altered_tumor_susceptibility | 3.75174068 |
| 3 | MP0000685_abnormal_immune_system | 3.65903219 |
| 4 | MP0005387_immune_system_phenotype | 3.58357932 |
| 5 | MP0001790_abnormal_immune_system | 3.58357932 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.28758160 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.05443519 |
| 8 | MP0001800_abnormal_humoral_immune | 3.00731525 |
| 9 | MP0002006_tumorigenesis | 2.83192110 |
| 10 | MP0003303_peritoneal_inflammation | 2.60163717 |
| 11 | MP0005360_urolithiasis | 2.46628608 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.39128817 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.32565443 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.25484466 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.20729125 |
| 16 | MP0005671_abnormal_response_to | 2.20048281 |
| 17 | MP0003866_abnormal_defecation | 2.19229342 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.19132699 |
| 19 | MP0003045_fibrosis | 2.13085264 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.09640910 |
| 21 | MP0005025_abnormal_response_to | 2.03050582 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.99108714 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.98483514 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.98048429 |
| 25 | MP0003436_decreased_susceptibility_to | 1.96400884 |
| 26 | MP0001819_abnormal_immune_cell | 1.95235676 |
| 27 | MP0002723_abnormal_immune_serum | 1.94518522 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.91853531 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.90582882 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.86286656 |
| 31 | MP0009785_altered_susceptibility_to | 1.81892590 |
| 32 | MP0003724_increased_susceptibility_to | 1.81585081 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.76685039 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.73234341 |
| 35 | MP0002398_abnormal_bone_marrow | 1.72449430 |
| 36 | MP0000716_abnormal_immune_system | 1.67729641 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.66616417 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.61526089 |
| 39 | MP0005310_abnormal_salivary_gland | 1.57450392 |
| 40 | MP0002163_abnormal_gland_morphology | 1.55536309 |
| 41 | MP0004957_abnormal_blastocyst_morpholog | 1.49412044 |
| 42 | MP0002429_abnormal_blood_cell | 1.47914889 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.44942685 |
| 44 | MP0002419_abnormal_innate_immunity | 1.42760164 |
| 45 | MP0005166_decreased_susceptibility_to | 1.37640409 |
| 46 | MP0001873_stomach_inflammation | 1.35140233 |
| 47 | MP0004782_abnormal_surfactant_physiolog | 1.32256570 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.31310876 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.29937946 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.29224304 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.26663838 |
| 52 | MP0010307_abnormal_tumor_latency | 1.26435031 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.25714497 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.24538499 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.22366155 |
| 56 | MP0002722_abnormal_immune_system | 1.19637555 |
| 57 | MP0006082_CNS_inflammation | 1.18419737 |
| 58 | MP0003868_abnormal_feces_composition | 1.16873067 |
| 59 | MP0003075_altered_response_to | 1.16210741 |
| 60 | MP0003786_premature_aging | 1.14001880 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.09771849 |
| 62 | MP0001663_abnormal_digestive_system | 1.04905728 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 1.01467849 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.01218244 |
| 65 | MP0005165_increased_susceptibility_to | 1.00839510 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 0.99679791 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 0.99478542 |
| 68 | MP0000490_abnormal_crypts_of | 0.95659693 |
| 69 | MP0003252_abnormal_bile_duct | 0.94816750 |
| 70 | MP0009643_abnormal_urine_homeostasis | 0.93720090 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93207184 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.88444695 |
| 73 | MP0002796_impaired_skin_barrier | 0.87941604 |
| 74 | MP0005365_abnormal_bile_salt | 0.84558412 |
| 75 | MP0003077_abnormal_cell_cycle | 0.84387629 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.83314477 |
| 77 | MP0004147_increased_porphyrin_level | 0.82804204 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.82212971 |
| 79 | MP0004858_abnormal_nervous_system | 0.79278005 |
| 80 | MP0002405_respiratory_system_inflammati | 0.77477730 |
| 81 | MP0009840_abnormal_foam_cell | 0.76653984 |
| 82 | MP0004947_skin_inflammation | 0.76366914 |
| 83 | MP0009379_abnormal_foot_pigmentation | 0.75278765 |
| 84 | MP0005275_abnormal_skin_tensile | 0.73149391 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.71816795 |
| 86 | MP0000477_abnormal_intestine_morphology | 0.70466711 |
| 87 | MP0005171_absent_coat_pigmentation | 0.69724169 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.69662423 |
| 89 | MP0005451_abnormal_body_composition | 0.66781790 |
| 90 | MP0008469_abnormal_protein_level | 0.65287519 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.64168802 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.63783364 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.61818593 |
| 94 | MP0000613_abnormal_salivary_gland | 0.60655231 |
| 95 | MP0001764_abnormal_homeostasis | 0.58600354 |
| 96 | MP0005503_abnormal_tendon_morphology | 0.58308834 |
| 97 | MP0000858_altered_metastatic_potential | 0.58271532 |
| 98 | MP0002168_other_aberrant_phenotype | 0.57601494 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.57252148 |
| 100 | MP0001853_heart_inflammation | 0.57000535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 4.71831312 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 4.53012941 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.39198519 |
| 4 | Abnormality of B cell number (HP:0010975) | 3.98565540 |
| 5 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.98028344 |
| 6 | Single umbilical artery (HP:0001195) | 3.98028344 |
| 7 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.98028344 |
| 8 | Agammaglobulinemia (HP:0004432) | 3.97105167 |
| 9 | Annular pancreas (HP:0001734) | 3.88934164 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 3.66936538 |
| 11 | Abnormality of the pulmonary veins (HP:0011718) | 3.55308208 |
| 12 | Abnormality of the prostate (HP:0008775) | 3.53965596 |
| 13 | Abnormality of T cell physiology (HP:0011840) | 3.32054211 |
| 14 | B lymphocytopenia (HP:0010976) | 3.17291048 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.11442524 |
| 16 | Chronic diarrhea (HP:0002028) | 3.11022317 |
| 17 | Neonatal death (HP:0003811) | 3.09986908 |
| 18 | Premature loss of primary teeth (HP:0006323) | 3.04395421 |
| 19 | Intestinal atresia (HP:0011100) | 3.01327926 |
| 20 | Vasculitis (HP:0002633) | 3.00122206 |
| 21 | Recurrent viral infections (HP:0004429) | 2.98098350 |
| 22 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.88809364 |
| 23 | Chronic sinusitis (HP:0011109) | 2.82100594 |
| 24 | Malnutrition (HP:0004395) | 2.81990019 |
| 25 | Meningitis (HP:0001287) | 2.76924511 |
| 26 | Papilledema (HP:0001085) | 2.75612949 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.71880812 |
| 28 | Verrucae (HP:0200043) | 2.64532118 |
| 29 | Papilloma (HP:0012740) | 2.64532118 |
| 30 | Hydroureter (HP:0000072) | 2.62709656 |
| 31 | Abnormality of the umbilical cord (HP:0010881) | 2.56836968 |
| 32 | Rhabdomyolysis (HP:0003201) | 2.56209569 |
| 33 | Osteomyelitis (HP:0002754) | 2.52606831 |
| 34 | Recurrent pneumonia (HP:0006532) | 2.50291261 |
| 35 | Colitis (HP:0002583) | 2.45955279 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.45603435 |
| 37 | IgM deficiency (HP:0002850) | 2.44575636 |
| 38 | Oral leukoplakia (HP:0002745) | 2.37725693 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.35230817 |
| 40 | Abnormal lung lobation (HP:0002101) | 2.34991312 |
| 41 | IgA deficiency (HP:0002720) | 2.34099638 |
| 42 | Lymphoma (HP:0002665) | 2.32549849 |
| 43 | Urticaria (HP:0001025) | 2.31287465 |
| 44 | Eosinophilia (HP:0001880) | 2.30870576 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 2.30364739 |
| 46 | Emphysema (HP:0002097) | 2.29147011 |
| 47 | Abnormality of T cells (HP:0002843) | 2.25987611 |
| 48 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25421963 |
| 49 | Cellulitis (HP:0100658) | 2.23782028 |
| 50 | Villous atrophy (HP:0011473) | 2.23079224 |
| 51 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.23079224 |
| 52 | Viral hepatitis (HP:0006562) | 2.21312707 |
| 53 | Hyperactive renin-angiotensin system (HP:0000841) | 2.20570495 |
| 54 | Amaurosis fugax (HP:0100576) | 2.19197213 |
| 55 | Skin rash (HP:0000988) | 2.18561673 |
| 56 | Lymphopenia (HP:0001888) | 2.17932756 |
| 57 | Increased IgE level (HP:0003212) | 2.17852426 |
| 58 | Conjunctival hamartoma (HP:0100780) | 2.17306999 |
| 59 | Hypoproteinemia (HP:0003075) | 2.16439023 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 2.16018081 |
| 61 | Granulocytopenia (HP:0001913) | 2.15317155 |
| 62 | Thyroiditis (HP:0100646) | 2.12320230 |
| 63 | Alkalosis (HP:0001948) | 2.12299440 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.12211818 |
| 65 | Chest pain (HP:0100749) | 2.11601809 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10483858 |
| 67 | Decreased circulating renin level (HP:0003351) | 2.08842396 |
| 68 | Restrictive lung disease (HP:0002091) | 2.07937664 |
| 69 | Recurrent sinusitis (HP:0011108) | 2.02113989 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.01205139 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 1.97587770 |
| 72 | Meckel diverticulum (HP:0002245) | 1.96834500 |
| 73 | Severe combined immunodeficiency (HP:0004430) | 1.94686666 |
| 74 | Inflammation of the large intestine (HP:0002037) | 1.94394154 |
| 75 | Abnormality of macrophages (HP:0004311) | 1.92508579 |
| 76 | Ileus (HP:0002595) | 1.89921920 |
| 77 | Neutropenia (HP:0001875) | 1.86034754 |
| 78 | Asplenia (HP:0001746) | 1.85558052 |
| 79 | Sepsis (HP:0100806) | 1.85179664 |
| 80 | Abnormality of complement system (HP:0005339) | 1.84337583 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 1.83880161 |
| 82 | Hypoplasia of the thymus (HP:0000778) | 1.82513516 |
| 83 | Melanoma (HP:0002861) | 1.79894681 |
| 84 | Hepatic necrosis (HP:0002605) | 1.79725739 |
| 85 | Squamous cell carcinoma (HP:0002860) | 1.79181512 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.78190265 |
| 87 | Hepatocellular necrosis (HP:0001404) | 1.77580119 |
| 88 | Neoplasm of head and neck (HP:0012288) | 1.76843423 |
| 89 | Esophageal neoplasm (HP:0100751) | 1.76843423 |
| 90 | Abnormality of the ileum (HP:0001549) | 1.75390104 |
| 91 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.74952531 |
| 92 | Abnormality of glycolysis (HP:0004366) | 1.74898230 |
| 93 | Recurrent abscess formation (HP:0002722) | 1.74493276 |
| 94 | Increased serum pyruvate (HP:0003542) | 1.73163147 |
| 95 | Metabolic alkalosis (HP:0200114) | 1.72558598 |
| 96 | Neoplasm of the adrenal gland (HP:0100631) | 1.71833117 |
| 97 | Combined immunodeficiency (HP:0005387) | 1.71797680 |
| 98 | Increased serum lactate (HP:0002151) | 1.71300943 |
| 99 | Duodenal stenosis (HP:0100867) | 1.71125226 |
| 100 | Small intestinal stenosis (HP:0012848) | 1.71125226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.50918082 |
| 2 | SMG1 | 5.28053540 |
| 3 | TAOK3 | 4.92021013 |
| 4 | ERN1 | 4.69944490 |
| 5 | EIF2AK3 | 4.29988841 |
| 6 | TAF1 | 4.01281370 |
| 7 | STK24 | 3.04769471 |
| 8 | BUB1 | 2.95102316 |
| 9 | EIF2AK1 | 2.48489968 |
| 10 | PIK3CG | 2.43433739 |
| 11 | RIPK4 | 2.01868795 |
| 12 | PRPF4B | 1.92260075 |
| 13 | TYK2 | 1.82629340 |
| 14 | MST4 | 1.80489029 |
| 15 | STK38L | 1.78698671 |
| 16 | MAPKAPK5 | 1.72143368 |
| 17 | CCNB1 | 1.66458925 |
| 18 | MAP4K1 | 1.64290689 |
| 19 | NEK1 | 1.60312708 |
| 20 | NUAK1 | 1.49400883 |
| 21 | FES | 1.31981949 |
| 22 | MAP3K10 | 1.22689209 |
| 23 | MELK | 1.21002691 |
| 24 | GRK6 | 1.20313300 |
| 25 | VRK1 | 1.14958343 |
| 26 | GRK5 | 1.13870074 |
| 27 | JAK3 | 1.06253442 |
| 28 | SYK | 1.03665545 |
| 29 | CDK8 | 0.96835212 |
| 30 | EIF2AK2 | 0.93087881 |
| 31 | BMPR2 | 0.92443427 |
| 32 | DAPK1 | 0.88042304 |
| 33 | PLK2 | 0.84997837 |
| 34 | IKBKE | 0.83687287 |
| 35 | MAPK7 | 0.82638755 |
| 36 | CDK9 | 0.78978691 |
| 37 | TBK1 | 0.78737190 |
| 38 | ALK | 0.78151516 |
| 39 | PLK3 | 0.77782398 |
| 40 | TTK | 0.76683966 |
| 41 | NME1 | 0.75214658 |
| 42 | BLK | 0.75057511 |
| 43 | STK4 | 0.70597752 |
| 44 | LYN | 0.69060556 |
| 45 | PDK2 | 0.67072599 |
| 46 | JAK1 | 0.66707926 |
| 47 | GRK1 | 0.65216694 |
| 48 | LRRK2 | 0.63771691 |
| 49 | MST1R | 0.63045735 |
| 50 | KIT | 0.62778495 |
| 51 | HIPK2 | 0.62283223 |
| 52 | IRAK3 | 0.61885194 |
| 53 | ITK | 0.61714254 |
| 54 | STK39 | 0.60570193 |
| 55 | IKBKB | 0.60319072 |
| 56 | IRAK4 | 0.56560966 |
| 57 | OXSR1 | 0.56145829 |
| 58 | FGFR4 | 0.55537388 |
| 59 | SIK2 | 0.53900219 |
| 60 | WEE1 | 0.51276416 |
| 61 | MKNK1 | 0.50362242 |
| 62 | PAK4 | 0.49617155 |
| 63 | CSK | 0.48141043 |
| 64 | ACVR1B | 0.45751286 |
| 65 | TLK1 | 0.45567120 |
| 66 | TXK | 0.44431958 |
| 67 | MAP3K13 | 0.44350439 |
| 68 | CDK6 | 0.43138516 |
| 69 | STK3 | 0.42433342 |
| 70 | ATR | 0.41449478 |
| 71 | NEK9 | 0.39804803 |
| 72 | NME2 | 0.39446923 |
| 73 | SIK3 | 0.39114467 |
| 74 | CDK7 | 0.38117273 |
| 75 | MAP2K6 | 0.36997111 |
| 76 | MAPK4 | 0.36522208 |
| 77 | RIPK1 | 0.34281158 |
| 78 | AURKB | 0.32948005 |
| 79 | HCK | 0.32295346 |
| 80 | PRKCI | 0.31840141 |
| 81 | EEF2K | 0.30485348 |
| 82 | JAK2 | 0.29727149 |
| 83 | LCK | 0.29518425 |
| 84 | MAP3K14 | 0.29067249 |
| 85 | BTK | 0.27532426 |
| 86 | IRAK1 | 0.27134497 |
| 87 | PRKCD | 0.26715078 |
| 88 | CSF1R | 0.26675972 |
| 89 | MKNK2 | 0.25713374 |
| 90 | PIK3CA | 0.25503681 |
| 91 | ZAK | 0.25032808 |
| 92 | MAPK11 | 0.24454570 |
| 93 | PRKCQ | 0.22645115 |
| 94 | DAPK3 | 0.22322415 |
| 95 | STK16 | 0.21967859 |
| 96 | MAPK12 | 0.21637550 |
| 97 | PIM1 | 0.20355639 |
| 98 | PRKAA2 | 0.19938099 |
| 99 | EPHA3 | 0.18961465 |
| 100 | AKT2 | 0.18424825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.49102085 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.90191127 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.51610261 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.51006967 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.50045449 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.08029421 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.06804614 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.75331993 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.68986427 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66722058 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.63336927 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.54282447 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35180789 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.34540714 |
| 15 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.29158183 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.26329924 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 2.24970352 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.14382939 |
| 19 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.04865632 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.92592499 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70275394 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.54289003 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49623183 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35888842 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.22414338 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18793190 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.18449735 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12247543 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10195545 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05628296 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02841179 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01134217 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 0.97991592 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97237411 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95146833 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92897540 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92495747 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91988598 |
| 39 | Measles_Homo sapiens_hsa05162 | 0.89813638 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89075659 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86290989 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83659244 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76539018 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74808754 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74786462 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 0.71161462 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69963029 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67106626 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67102395 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.64962779 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64901051 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64302803 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.62514083 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62423535 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61234225 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58064001 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56211716 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54836784 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.51460600 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50300911 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48841739 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48209807 |
| 63 | Homologous recombination_Homo sapiens_hsa03440 | 0.48164622 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46536170 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46280695 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45827029 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.43138629 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42065868 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41991545 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41321647 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39952586 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.37812895 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37602150 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37422911 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32347079 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32114337 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30062118 |
| 78 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29028222 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.28942990 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28718500 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.28039861 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27962634 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.27780714 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.27308768 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26252755 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.25956499 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25883308 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25244663 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23936894 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23122984 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22847858 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.21963214 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.21690455 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20689118 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.20477512 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18248555 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17615557 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16802610 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15358063 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.14842793 |

